The DOI matches its Crossref record; 341 of the 364 references it cites were found in a registry or an index; 4 of the 273 sources its claims cite were checked for support.
The Pathobiology of Vascular Dementia
Open accessAbstract
Vascular cognitive impairment defines alterations in cognition, ranging from subtle deficits to full-blown dementia, attributable to cerebrovascular causes. Often coexisting with Alzheimer's disease, mixed vascular and neurodegenerative dementia has emerged as the leading cause of age-related cognitive impairment. Central to the disease mechanism is the crucial role that cerebral blood vessels play in brain health, not only for the delivery of oxygen and nutrients, but also for the trophic signaling that inextricably links the well-being of neurons and glia to that of cerebrovascular cells. This review will examine how vascular damage disrupts these vital homeostatic interactions, focusing on the hemispheric white matter, a region at heightened risk for vascular damage, and on the interplay between vascular factors and Alzheimer's disease. Finally, preventative and therapeutic prospects will be examined, highlighting the importance of midlife vascular risk factor control in the prevention of late-life dementia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
161 Not checked yet · 47 Own interpretation · 2 Partly supported · 1 Supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“community based clinical-pathological studies revealed that the largest proportion of dementia cases have mixed pathology, comprising features of AD (amyloid plaques and neurofibrillary tangles) as well as ischemic lesions (Launer et al., 2008; Schneider et al., 2009).”
§ The pathobiology of vascular dementia > Dementia through the ages
What the sources say
- Partly supportedcites Launer et al., 2008 sourceExperimental — accuracy not yet measured
The Results report that plaques and vascular lesions co-occurred in 50.6% of the community-based autopsy sample, and the Conclusion describes a high prevalence of co-morbid AD markers and vascular lesions. But the paper does not establish that the largest proportion of dementia cases specifically had both plaques and tangles alongside ischemic lesions; only 29% of the sample had dementia before death. (LLM, conf=0.86)
- Partly supportedcites Schneider et al., 2009 sourceExperimental — accuracy not yet measured
The Discussion says mixed pathologies were the most common substrate for dementia in several community-dwelling cohorts. In this study, the Results report mixed pathology in 45.8% of people with probable AD, with AD plus infarcts the most common combination. The paper therefore supports mixed pathology as a leading pattern, but not the claim that most dementia cases specifically combined AD features with ischemic lesions; some mixed cases involved Lewy bodies. (LLM, conf=0.84)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“whereas amyloid accumulation is reduced in patients who exercise regularly (Liang et al., 2010).”
§ The pathobiology of vascular dementia > Overlap between vascular and neurodegenerative dementia > Aβ production and clearance
What the sources say
- Partly supportedcites Liang et al., 2010 sourceExperimental — accuracy not yet measured
The Results section reports lower amyloid deposition, measured by PIB binding, among cognitively normal older adults who met exercise guidelines. The paper describes an association, not evidence that exercise reduced accumulation, and its participants were cognitively normal rather than patients with Alzheimer’s disease. The adjusted group difference also depended on removing an outlier. (LLM, conf=0.88)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
In the paper
“Owing to its high energy needs and lack of fuel reserves, the brain requires a continuous and well-regulated supply of blood (Iadecola, 2004).”
§ The pathobiology of vascular dementia > The neurovascular unit: blood flow regulation and beyond
What the sources say
- Not checked yetcites Iadecola, 2004 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“new experimental findings have revealed a previously unrecognized functional and pathogenic synergy between neurons, glia and vascular cells (Iadecola, 2010; Quaegebeur et al., 2011; Zlokovic, 2011)”
§ The pathobiology of vascular dementia > Introduction
What the sources say
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Consequently, neural activity, which uses most of the brain’s energy budget, is the major determinant of the dynamic regulation of CBF.”
§ The pathobiology of vascular dementia > The neurovascular unit: blood flow regulation and beyond > Neurovascular control mechanisms
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Central to the disease mechanism is the crucial role that cerebral blood vessels play in brain health, not only for the delivery of oxygen and nutrients, but also for the trophic signaling that links inextricably the well being of neurons and glia to that of cerebrovascular cells.”
§ The pathobiology of vascular dementia > Abstract
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Reduction in global cerebral perfusion caused by cardiac arrest, arrhythmias, cardiac failure, or hypotension can produce brain dysfunction and impair cognition transiently or permanently (table 1) (Alosco et al., 2013; Justin et al., 2013; Marshall, 2012; Stefansdottir et al., 2013).”
§ The pathobiology of vascular dementia > Cerebrovascular pathologies underlying cognitive impairment are diverse > Reduced cerebral perfusion and post-stroke dementia
What the sources say
- Not checked yetcites Alosco et al., 2013 source
- Not checked yetcites Justin et al., 2013
- Not checked yetcites Marshall, 2012
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Often coexisting with Alzheimer’s disease, mixed vascular and neurodegenerative dementia has emerged as the leading cause of age-related cognitive impairment.”
§ The pathobiology of vascular dementia > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The vascular alterations that cause cognitive impairment are diverse, and include systemic conditions affecting global cerebral perfusion or alterations involving cerebral blood vessels, most commonly small size arterioles or venules (fig. 5).”
§ The pathobiology of vascular dementia > Cerebrovascular pathologies underlying cognitive impairment are diverse
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“By far, the most prevalent vascular lesions associated with VCI are related to alterations in small vessels in the hemispheric white matter (Jellinger, 2013).”
§ The pathobiology of vascular dementia > Cerebrovascular pathologies underlying cognitive impairment are diverse > Small vessel disease, leukoaraiosis and lacunar infarcts
What the sources say
- Not checked yetcites Jellinger, 2013 source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 77
- Probably not a substantial claim. 6
Every source the paper cites for this claim was checked and supports it.
In the paper
“In white matter lesions, HA is degraded by the hyaluronidase PH20 and its cleavage products inhibit the maturation of OPC into oligodendrocytes capable of myelination (Preston et al., 2013) (fig. 7).”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Demyelination and remyelination
What the sources say
- Supportedcites Preston et al., 2013 source
The Discussion describes the authors’ model in which PH20 degrades hyaluronan in CNS lesions and the resulting products inhibit OPC maturation. The Abstract’s Results report that PH20-generated HA digestion products inhibited OPC maturation into oligodendrocytes and remyelination in demyelinating lesions. (LLM, conf=0.94)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, the neurovascular unit is an important checkpoint regulating the afferent and efferent arms of the immune system and shaping the immune responses of the brain.”
§ The pathobiology of vascular dementia > The neurovascular unit: blood flow regulation and beyond > Immune trafficking and regulation
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Recent clinical-pathological studies have highlighted the role of cerebrovascular disease, not only as a primary cause of cognitive impairment, but also as an adjuvant to the expression of dementia caused by other factors, including AD and other neurodegenerative pathologies (Gorelick et al., 2011; Schneider et al., 2007a; Toledo et al., 2013).”
§ The pathobiology of vascular dementia > Introduction
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“occlusion of penetrating arterioles or venules, unlike pial vessels, cannot be effectively compensated by anastomotic branches (Blinder et al., 2013), and results in reductions in flow sufficient to produce small ischemic lesions akin to microinfarcts (Nguyen et al., 2011; Nishimura et al., 2010; Shih et al., 2013).”
§ The pathobiology of vascular dementia > The neurovascular unit: blood flow regulation and beyond > The brain vascular network and neurovascular unit
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“regions of the deep white matter are supplied by long penetrating arterioles arising from the pial cortical network at the border between non-overlapping vascular territories of the anterior and middle cerebral arteries, and as such are more vulnerable to reductions in blood flow (Brown and Thore, 2011; De Reuck, 1971)”
§ The pathobiology of vascular dementia > The neurovascular unit: blood flow regulation and beyond > The brain vascular network and neurovascular unit
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Due to fewer synapses, white matter energy usage, and consequently blood flow, is 1/3 lower of that of the gray matter (Harris and Attwell, 2012).”
§ The pathobiology of vascular dementia > The neurovascular unit: blood flow regulation and beyond
What the sources say
- Not checked yetcites Harris and Attwell, 2012
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Vascular dementia, a heterogeneous group of brain disorders in which cognitive impairment is attributable to cerebrovascular pathologies, is responsible for at least 20% of cases of dementia, being second only to Alzheimer’s disease (AD) (Gorelick et al., 2011).”
§ The pathobiology of vascular dementia > Introduction
What the sources say
- Not checked yetcites Gorelick et al., 2011 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, neurovascular cells are trophically and metabolically interdependent, such that damage to one cell type removes a vital source of support to the whole unit and has deleterious consequences also for the other cell types.”
§ The pathobiology of vascular dementia > The neurovascular unit: blood flow regulation and beyond > Trophic coupling in the neurovascular unit
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The brain vasculature has an intimate developmental, structural and functional relationship with the brain tissue, their cellular elements forming a functional domain termed the neurovascular unit (Iadecola, 2004).”
§ The pathobiology of vascular dementia > The neurovascular unit: blood flow regulation and beyond
What the sources say
- Not checked yetcites Iadecola, 2004 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Stroke doubles the risk for dementia (post-stroke dementia), and approximately 30% of stroke patients go on to develop cognitive dysfunction within 3 years (Allan et al., 2011; Leys et al., 2005; Pendlebury and Rothwell, 2009).”
§ The pathobiology of vascular dementia > Cerebrovascular pathologies underlying cognitive impairment are diverse > Reduced cerebral perfusion and post-stroke dementia
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The ApoE 4 allele is a well-established susceptibility gene for increased cardiovascular risk and Alzheimer disease (Verghese et al., 2011).”
§ The pathobiology of vascular dementia > Risk factors for vascular cognitive impairments
What the sources say
- Not checked yetcites Verghese et al., 2011 source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“The ApoE4 allele is associated with increased risk of CAA, whereas both ApoE2 and 4 increase the risk of lobar hemorrhages (Charidimou et al., 2012).”
§ The pathobiology of vascular dementia > Risk factors for vascular cognitive impairments
What the sources say
- Not checked yetcites Charidimou et al., 2012 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The most common of these is the CADASIL syndrome caused by a frame shift mutation of Notch-3 that either creates or eliminates a cystein residue (Chabriat et al., 2009).”
§ The pathobiology of vascular dementia > Risk factors for vascular cognitive impairments
What the sources say
- Not checked yetcites Chabriat et al., 2009 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Advanced age is a powerful risk factor for VCI, and the prevalence and incidence of cognitive impairment increases exponentially after age 65 (Gorelick et al., 2011).”
§ The pathobiology of vascular dementia > Risk factors for vascular cognitive impairments
What the sources say
- Not checked yetcites Gorelick et al., 2011 source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Reductions in CBF by 40–50% are associated with suppression of brain activity and cognitive dysfunction, which are reversible upon re-establishing normal CBF levels (Marshall et al., 1999; Marshall, 2012; Tatemichi et al., 1995).”
§ The pathobiology of vascular dementia > Cerebrovascular pathologies underlying cognitive impairment are diverse > How do vascular factors cause cognitive impairment?
What the sources say
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Indeed, white matter lesions affect brain structure and function broadly, and are associated with reductions in frontal lobe glucose utilization (Decarli et al., 1995; Haight et al., 2013; Tullberg et al., 2004), global reduction in cortical blood flow (Appelman et al., 2008; Chen et al., 2013a; Dam et al., 2007; Kobari et al., 1990), disruption of brain connectivity (Lawrence et al., 2013; Sun et”
§ The pathobiology of vascular dementia > Cerebrovascular pathologies underlying cognitive impairment are diverse > How do vascular factors cause cognitive impairment?
What the sources say
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Linkage studies in patients with white matter lesions on MRI have discovered several loci (Schmidt et al., 2012), but no specific gene has been identified and the findings await replication and validation (Lee and Kim, 2013; Markus, 2008).”
§ The pathobiology of vascular dementia > Risk factors for vascular cognitive impairments
What the sources say
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“GWAS of vascular dementia have shown small effect of SNPs in the androgen receptor gene locus (Schrijvers et al., 2012), a finding not observed in all ethnic groups (Lee and Kim, 2013).”
§ The pathobiology of vascular dementia > Risk factors for vascular cognitive impairments
What the sources say
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The expansion of the white matter lesions correlates with the evolution of the cognitive impairment (Maillard et al., 2012), new lacunes causing a steeper decline, especially in motor speed and executive functions (Jokinen et al., 2011).”
§ The pathobiology of vascular dementia > Cerebrovascular pathologies underlying cognitive impairment are diverse > Small vessel disease, leukoaraiosis and lacunar infarcts
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In addition, since myelination of previously naked fibers participates in neuroplasticity and skilled motor learning (Fields, 2010; Richardson et al., 2011), myelin damage could also compromise these important functions and contribute to cognitive impairment.”
§ The pathobiology of vascular dementia > Cerebrovascular pathologies underlying cognitive impairment are diverse > How do vascular factors cause cognitive impairment?
What the sources say
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“However, the education level does not influence the rate of progression of VCI and no longer has an impact in advanced disease (Elbaz et al., 2013; Zieren et al., 2013).”
§ The pathobiology of vascular dementia > Risk factors for vascular cognitive impairments
What the sources say
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Confluent white matter lesions, the imaging correlate of which is termed leukoaraiosis (fig. 3), and lacunes, small (<1.5 cm) white matter infarcts typically in the basal ganglia, are common occurrence in VCI and are strongly associated with cardiovascular risk factors, especially hypertension, diabetes, hyperlipidemia and smoking (Gorelick et al., 2011; Wardlaw et al., 2013b).”
§ The pathobiology of vascular dementia > Cerebrovascular pathologies underlying cognitive impairment are diverse > Small vessel disease, leukoaraiosis and lacunar infarcts
What the sources say
- Not checked yetcites Gorelick et al., 2011 source
- Not checked yetcites Wardlaw et al., 2013b
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Resting flow is reduced in areas of leukoaraiosis and vascular reactivity attenuated (Kobari et al., 1990; Makedonov et al., 2013; Markus et al., 2000; 1994; Marstrand et al., 2002; O’Sullivan et al., 2002; Yao et al., 1992).”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Hypoperfusion and hypoxia
What the sources say
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Cerebrovascular autoregulation is impaired, increasing the susceptibility of the white matter to damage during fluctuation in blood pressure (Matsushita et al., 1994).”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Hypoperfusion and hypoxia
What the sources say
- Not checked yetcites Matsushita et al., 1994 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Furthermore, stiffness of large vessels and increased pulsatility are associated with reduced white matter CBF and are strong predictors of leukoaraiosis and lacunes (Brisset et al., 2013; Tarumi et al., 2011; Webb et al., 2012), independently of vascular risk factors (Kearney-Schwartz et al., 2009).”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Hypoperfusion and hypoxia
What the sources say
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Owing to their location at the distal border between different vascular territories (De Reuck, 1971) (fig 4) and to the susceptibility of their vasculature to risk factors (Brown and Thore, 2011), deep white matter tracts are particularly vulnerable to vascular insufficiency.”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Hypoperfusion and hypoxia
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Interestingly, CBF alterations have also been described in normal appearing white matter (O’Sullivan et al., 2002), suggesting that the flow reduction precedes and, as such, may contribute to the white matter damage.”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Hypoperfusion and hypoxia
What the sources say
- Not checked yetcites O’Sullivan et al., 2002 source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“EPC are reduced by stroke risk factors (Hill et al., 2003) and predict cardiovascular morbidity and mortality (Werner et al., 2005).”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Trophic uncoupling
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The latter finding suggests that the BBB disruption could precede white matter injury and contribute to its development.”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Increased blood-brain barrier permeability
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Hypoxia-ischemia, which has been demonstrated in white matter lesions, is well known to damage endothelial cells leading to increased BBB leakage in vitro (Ahmad et al., 2012).”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Increased blood-brain barrier permeability
What the sources say
- Not checked yetcites Ahmad et al., 2012 source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“EPC are reduced in age associated white matter lesions, the reduction correlating with lesion burden (Jickling et al., 2009).”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Trophic uncoupling
What the sources say
- Not checked yetcites Jickling et al., 2009 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“BBB leakiness in white matter was found in lacunar strokes, but not cortical strokes (Wardlaw et al., 2008), raising the possibility of a specific association with small vessel disease of the deep white matter.”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Increased blood-brain barrier permeability
What the sources say
- Not checked yetcites Wardlaw et al., 2008 source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“NADPH oxidase, a multiunit enzyme particularly enriched in cerebral blood vessels (Miller et al., 2005), has emerges as an important source in vascular oxidative stress in aging, hypertension, hyperlipidemia and diabetes (Faraci, 2011), and inhibition or genetic inactivation of this enzyme has been shown to ameliorate the vascular dysfunction (Drummond et al., 2011).”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Oxidative stress and inflammation
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Angiogenic T-cells are reduced in patients with vascular risk factors (Hur et al., 2007; Weil et al., 2011), and in hypertensive patients with small vessels disease (Rouhl et al., 2012b).”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Trophic uncoupling
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Interestingly, EPC colony forming units are also reduced in AD patients, in whom the magnitude of the reduction correlates with the degree of cognitive impairment (Lee et al., 2009).”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Trophic uncoupling
What the sources say
- Not checked yetcites Lee et al., 2009 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Cerebral hypoperfusion is associated with white matter inflammation and oxidative stress in rodent models (Dong et al., 2011; Huang et al., 2010; Ihara et al., 2001; Juma et al., 2011; Masumura et al., 2001; Reimer et al., 2011; Yoshizaki et al., 2008), indicating that hypoxia-ischemia is sufficient to trigger these responses.”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Oxidative stress and inflammation
What the sources say
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Such neurovascular dysfunction would aggravate the CBF reduction in critically perfused deep white matter regions and contribute to the white matter damage.”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Oxidative stress and inflammation
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Third, the permeability to MRI tracers is increased in white matter lesions (Hanyu et al., 2002; Taheri et al., 2011; Wardlaw et al., 2009) and in normal appearing white matter (Topakian et al., 2010).”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Increased blood-brain barrier permeability
What the sources say
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In a similar model, the BBB alteration was found to be due to MMP9 production by oligodendrocyte precursors, which are increased in ischemic white matter injury in rodent models (Seo et al., 2013) and in patients with VCI (Candelario-Jalil et al., 2011).”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Increased blood-brain barrier permeability
What the sources say
- Not checked yetcites Seo et al., 2013
- Not checked yetcites Candelario-Jalil et al., 2011 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Endothelial dysfunction has two major pathogenic consequences: reductions in resting CBF in the marginally perfused white matter, and alterations in the permeability of the BBB.”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Putting it all together
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In addition, OPC produce MMP9, which, as seen in the previous sections, promotes BBB breakdown perpetuating the cytotoxic milieu underlying demyelination (Seo et al., 2013).”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Demyelination and remyelination
What the sources say
- Not checked yetcites Seo et al., 2013
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“However, in MS patients CBF is reduced in the normal appearing white matter (Law et al., 2004), as well as in the gray matter (D’haeseleer et al., 2011).”
§ The pathobiology of vascular dementia > Is hypoperfusion involved also in inherited and autoimmune white matter diseases?
What the sources say
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These findings, raise the possibility that vascular risk factors suppress the production of angiogenic T-cells, reduce the repair potential of EPC, and contribute to the microvascular degeneration underlying leukoaraiosis and lacunar stroke.”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Trophic uncoupling
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, demyelination exposes the axons to the deleterious effects of cytokine and free radicals in the hypoxic white matter, which may impair axonal energy production leading to failure of the Na+/K+ ATPase.”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Demyelination and remyelination
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Myelination allows axons to conduct 100 times faster, and reduce energy expenditures by restricting the depolarization of the axonal membrane to the Na+ channel rich Ranvier nodes (Nave, 2010b).”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Demyelination and remyelination
What the sources say
- Not checked yetcites Nave, 2010b
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In its infantile form, the disease starts between 4 and 8 years of age and is characterized by a progressive cognitive decline associated with rampant inflammatory demyelination of the white matter (Moser et al., 2000).”
§ The pathobiology of vascular dementia > Is hypoperfusion involved also in inherited and autoimmune white matter diseases?
What the sources say
- Not checked yetcites Moser et al., 2000 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Multiple sclerosis (MS) is the prototypical neuroinflammatory disease in which demyelination is thought to be related to a T-cell mediated autoimmune attack on myelin (McFarland and Martin, 2007).”
§ The pathobiology of vascular dementia > Is hypoperfusion involved also in inherited and autoimmune white matter diseases?
What the sources say
- Not checked yetcites McFarland and Martin, 2007 source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Vessels devoid of endothelium (string vessels) are often observed, reflecting a failure of endothelial repair, possibly due to EPC dysfunction or loss of neuron and/or glial-derived growth factors.”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Trophic uncoupling
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Upregulation of VNa+1.2 channels increases the activity of the Na+/K+ ATPase, stressing further the energy budget of the marginally perfused white matter (Trapp and Stys, 2009).”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Demyelination and remyelination
What the sources say
- Not checked yetcites Trapp and Stys, 2009 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In addition to the brain dysfunction caused by slowing down the transmission of axon potentials, demyelination threatens the integrity of the axons and leads to axonal loss (Franklin and Ffrench-Constant, 2008; Matute and Ransom, 2012).”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Demyelination and remyelination
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, loss of myelin deprives the axons of trophic support and increases their vulnerability.”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Demyelination and remyelination
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Furthermore, the adaptive upregulation of voltage-dependent Na+ channels (VNa+) in the denuded internodal axoplasm, attempting to preserve impulse propagation in demyelinated axons, leads to Na+ entry and aggravates the energy deficit and Ca2+ overload.”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Demyelination and remyelination
What the sources say
- Not checked yetcites Trapp and Stys, 2009 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In turn, excess intracellular Ca2+ activates protease dependent processes that lead to microtubule fragmentation and perturbation of axonal flow (Franklin and Ffrench-Constant, 2008; Matute and Ransom, 2012).”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Demyelination and remyelination
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Reductions in white matter CBF has also been found X-linked adrenoleukodystrophy (ALD), a disease caused by mutations in ABCD1, which encodes a peroxisomal membrane transporter protein, leading to accumulation of very long chain fatty acids in brain, spinal cord and adrenal glands (Moser et al., 2000).”
§ The pathobiology of vascular dementia > Is hypoperfusion involved also in inherited and autoimmune white matter diseases?
What the sources say
- Not checked yetcites Moser et al., 2000 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Leukoaraiosis is associated with focal cortical thinning especially in frontal cortex, a finding correlated with executive dysfunction (Seo et al., 2012).”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Trophic uncoupling
What the sources say
- Not checked yetcites Seo et al., 2012 source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Hypoxia, inflammation and oxidative stress damage oligodendrocytes and leads to trophic uncoupling in the neurovascular unit, which, in turn, contribute to the damage to vascular cells and oligodendrocytes.”
§ The pathobiology of vascular dementia > Pathogenic mechanisms responsible for white matter injury > Putting it all together
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Aged APP mice deficient in CD36 are protected from cerebrovascular alterations and behavioral deficits, effects associated with reduced CAA compared to controls, but no reduction of amyloid plaques (Park et al., 2013b).”
§ The pathobiology of vascular dementia > Overlap between vascular and neurodegenerative dementia > Vascular effects of Aβ
What the sources say
- Not checked yetcites Park et al., 2013b
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As discussed in the section on “Mixed lesions”, AD brains have a wide variety of vascular lesions, suggesting a potential pathogenic interaction between vascular factors and AD.”
§ The pathobiology of vascular dementia > Overlap between vascular and neurodegenerative dementia
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The vascular alterations induced by Aβ are abrogated by overexpression of the ROS scavenging enzyme superoxide dismutase or deficiency of the NADPH oxidase subunit NOX2 (Iadecola et al., 1999; Park et al., 2005; 2008)”
§ The pathobiology of vascular dementia > Overlap between vascular and neurodegenerative dementia > Vascular effects of Aβ
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These data suggest that the cerebrovascular effects of Aβ are not attributable to CAA or amyloid plaques, and are not a consequence of neuronal energy hypometabolism.”
§ The pathobiology of vascular dementia > Overlap between vascular and neurodegenerative dementia > Vascular effects of Aβ
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Conversely, some studies (Jendroska et al., 1995; Ly et al., 2012), but not others (Aho et al., 2006; Mastaglia et al., 2003), have reported increased amyloid deposition in stroke patients, implicating that ischemia promotes AD pathology.”
§ The pathobiology of vascular dementia > Overlap between vascular and neurodegenerative dementia > Cerebrovascular factors and AD
What the sources say
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The realization that most cases of dementia have mixed pathological features has raised the intriguing possibility that vascular factors play role in AD and other neurodegenerative diseases.”
§ The pathobiology of vascular dementia > Overlap between vascular and neurodegenerative dementia
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“application of Aβ4 to the exposed cerebral cortex of mice reduces CBF and impairs the increase in CBF induced by endothelium-dependent vasodilators and functional hyperemia (Niwa et al., 2000a; 2000b)”
§ The pathobiology of vascular dementia > Overlap between vascular and neurodegenerative dementia > Vascular effects of Aβ
What the sources say
- Not checked yetcites Niwa et al., 2000a
- Not checked yetcites Niwa et al., 2000b
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In advanced cases of AD, vascular lesions do not seem to have a major influence on the progression of the cognitive deficits, suggesting the AD pathology is the major driver of the cognitive dysfunction (Chui et al., 2006; Jellinger, 2001).”
§ The pathobiology of vascular dementia > Overlap between vascular and neurodegenerative dementia
What the sources say
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“functional hyperemia, endothelium-dependent responses and autoregulation are profoundly impaired in young mice overexpressing mutated forms of APP, in which brain Aβ is elevated, but there are no plaques, behavioral alterations, or reductions in resting glucose utilization (Niwa et al., 2000b; 2002; Tong et al., 2012)”
§ The pathobiology of vascular dementia > Overlap between vascular and neurodegenerative dementia > Vascular effects of Aβ
What the sources say
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Cerebrovascular function is reduced in patients with early AD or at risk for AD (Claassen et al., 2009; Gao et al., 2013; Luckhaus et al., 2008; Mentis et al., 1996; Niedermeyer, 2006; Ruitenberg et al., 2005; Sabayan et al., 2012; Tanaka et al., 2002), implicating reduced cerebral perfusion in the pathobiology of the disease (Iadecola, 2004).”
§ The pathobiology of vascular dementia > Overlap between vascular and neurodegenerative dementia > Cerebrovascular factors and AD
What the sources say
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Furthermore, the correlation was strongest for vascular dementia and weakest for AD, suggesting that vascular risk factors may independently increase the likelihood of dementia without exacerbating AD pathology (Chui et al., 2012).”
§ The pathobiology of vascular dementia > Overlap between vascular and neurodegenerative dementia > Cerebrovascular factors and AD
What the sources say
- Not checked yetcites Chui et al., 2012
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Indeed, rigorous blood pressure control reduces white matter damage and staves off cognitive decline (Sharp et al., 2011; Sörös et al., 2013).”
§ The pathobiology of vascular dementia > Prospects for prevention and therapy
What the sources say
- Not checked yetcites Sharp et al., 2011 source
- Not checked yetcites Sörös et al., 2013
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Some agents, like the neurotrophic factor cerebrolysin, showed a modest cognitive improvement, but the evidence is not sufficiently strong to justify clinical use (Chen et al., 2013b).”
§ The pathobiology of vascular dementia > Prospects for prevention and therapy
What the sources say
- Not checked yetcites Chen et al., 2013b
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“VCI and vascular dementia are major contributors to age-relate dementing illnesses and comprise a heterogeneous group of cognitive disorders attributable to vascular causes.”
§ The pathobiology of vascular dementia > Conclusions
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
In the paper
“Furthermore, due to frequent overlap with AD, the diagnosis of VCI can be challenging, complicating the choice of the best therapeutic approach (Wang et al., 2012).”
§ The pathobiology of vascular dementia > Conclusions
What the sources say
- Not checked yetcites Wang et al., 2012 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Physical and mental activity, social engagement, and a diet rich in antioxidants or polyunsaturated fatty acids reduce dementia risk (Aarsland et al., 2010; Akinyemi et al., 2013; Middleton and Yaffe, 2009; Verdelho et al., 2012).”
§ The pathobiology of vascular dementia > Prospects for prevention and therapy
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“A study in the UK population suggests that the prevalence of dementia may be decreasing, a finding interpreted to reflect the beneficial effects of controlling blood pressure and other risk factors (Matthews et al., 2013).”
§ The pathobiology of vascular dementia > Prospects for prevention and therapy
What the sources say
- Not checked yetcites Matthews et al., 2013 source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Despite these positive results in models of hypoperfusion-induced white matter damage, there are no FDA approved treatments for VCI and vascular dementia (Butler and Radhakrishnan, 2012).”
§ The pathobiology of vascular dementia > Prospects for prevention and therapy
What the sources say
- Not checked yetcites Butler and Radhakrishnan, 2012
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Despite the diversity of the underlying brain pathology, the vascular alterations have a similar pathogenic bases, resulting from hypoperfusion, oxidative stress and inflammation, which in turn lead to endothelial damage, BBB breakdown, activation of innate immunity and disruption of trophic coupling between vascular and brain cells.”
§ The pathobiology of vascular dementia > Conclusions
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The hemispheric white matter, which is particularly susceptible to the deleterious effects of vascular risk factors, is a major target of these vascular alterations.”
§ The pathobiology of vascular dementia > Conclusions
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The role of hypoperfusion, BBB disruption, oxidative stress and inflammation is well established in animal models of white matter damage, but therapies based on these pathogenic mechanisms have not been successful.”
§ The pathobiology of vascular dementia > Conclusions
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“However, most of the evidence is based on observational studies, which have not been confirmed by randomized clinical trials of risk factor modification, stressing the need for further large scale studies (Dichgans and Zietemann, 2012; Middleton and Yaffe, 2009).”
§ The pathobiology of vascular dementia > Prospects for prevention and therapy
What the sources say
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Vascular risk factors can increase amyloid accumulation and the risk of clinically defined AD.”
§ The pathobiology of vascular dementia > Overlap between vascular and neurodegenerative dementia > Aβ production and clearance
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
Mechanisms observed in animal models of cerebral hypoperfusion and white matter injury are representative of the pathogenic processes in human vascular cognitive impairment.
“Cerebral hypoperfusion is associated with white matter inflammation and oxidative stress in rodent models (Dong et al., 2011; Huang et al., 2010; Ihara et al., 2001; Juma et al., 2011; Masumura et al., 2001; Reimer et al., 2011; Yoshizaki et al., 2008), indicating that hypoxia-ischemia is sufficient to trigger these responses.”
“In vivo, hypoperfusion produced by bilateral carotid stenosis in rat increases BBB permeability (Ueno et al., 2002).”
The paper relies on this without support.
The vascular risk factors and pathological processes identified in the reviewed studies are representative of the general population with vascular cognitive impairment.
“Ascertaining the genetic and modifiable risk factors of VCI is problematic due to the multiplicity of underlying pathologies, coexistence with cardiovascular diseases, and the frequent overlap with AD and other neurodegenerative diseases (Gorelick et al., 2011).”
The paper relies on this without support.
Mixed dementia is the most common cause of dementia in the elderly.
“Considering that mixed dementia is the most common cause of dementia in the elderly”
The paper relies on this without support.
Dementia has a long preclinical phase.
“the long preclinical phase of dementia is problematic, since, in VCI as in AD, initiating therapy when patients become symptomatic may be too late.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Different cell types of the neurovascular unit (NVU) including vascular cells [e.g., endothelium and mural cells including pericytes and smooth muscle cells (SMCs)], glia (e.g., astrocytes, microglia), and neurons contribute to regulation of BBB permeability, neurovascular coupling, cell-matrix interactions, neurotransmitter turnover, and angiogenesis and neurogenesis (270, 271, 692, 693)”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [270]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In patients and mouse models of AD, fibrinogen extravasates in the brain at sites of impaired blood-brain barrier integrity and cerebrovascular dysfunction, which are early features of AD pathogenesis.21,39-42”
From Machine learning reveals prominent spontaneous behavioral changes and treatment efficacy in humanized and transgenic Alzheimer's disease models (2024) · cites this paper as [41]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“which is associated with cerebral blood flow (CBF) reductions and dysregulation (269-271, 318), contributing to neurological deficits.”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [270]
In the citing paper
“In principle, any of the multiple causes of clinical stroke can cause vascular cognitive impairment.”
From Vascular Cognitive Impairment (2017) · cites this paper as [44]
In the citing paper
“Deterioration of the vascular bed may occur alone or in combination with other pathologies (97), leading to progressive demyelination and loss of white matter (98).”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [97]
Citations
Cites
Wardlaw, J. M., Smith, E. E., Biessels, G. J., Cordonnier, C., Fazekas, F., Frayne, R., Lindley, R. I., O'Brien, J. T., Barkhof, F., Benavente, O. R., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70124-8 · Cited by 5,544
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467 · cited 1×
“In the developing nervous system, prototypical neural guidance signals, ephrins, netrins, slit glycoproteins, and semaphorins also contribute to endothelial tip cell guidance (Carmeliet and Jain, 2011).”
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404 · cited 1×
“…considered a major player in dementia well into the 20th century, until, in the 1980s, the Ab peptide was identified as the main component of parenchymal (amyloid plaque) and vascular (amyloid angiopathy) amyloid deposits, pathological hallmarks of AD (Glenner and Wong, 1984; Kang et al., 1987).”
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619 · cited 2×
“Vascular factors were considered a major player in dementia well into the 20 century, until, in the 1980s, the Ab peptide was identified as the main component of parenchymal (amyloid plaque) and vascular (amyloid angiopathy) amyloid deposits, pathological hallmarks of AD (Glenner and Wong, 1984; Kang et al., 1987).”
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Self-citationCognitive reserve in ageing and Alzheimer's disease
Stern, Y. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70191-6 · Cited by 3,557 · cited 1×
“The level of education, a surrogate marker of cognitive reserves (Stern, 2012), is an important determinant of the expression of VCI, such that for a given level of neuropathology higher education is associated with less cognitive deficits (Zieren et al., 2013).”
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
Hill, J. M., Zalos, G., Halcox, J. P. J., Schenke, W. H., Waclawiw, M. A., Quyyumi, A. A., & Finkel, T. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022287 · Cited by 3,423
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969 · cited 2×
“…a previously unrecognized functional and pathogenic synergy between neurons, glia, and vascular cells (Iadecola, 2010; Quaegebeur et al., 2011; Zlokovic, 2011), providing a new framework to reevaluate how alterations in cerebral blood vessels could contribute to the neuronal dysfunction…”
Research works printed but not linked: 1
- Butler, 2012, Dementia, Clin. Evid. (Online)
Cited by
Sorted by citations
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
Iadecola, C. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.030 · Cited by 2,480
Self-citationBlood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
A molecular atlas of cell types and zonation in the brain vasculature
Vanlandewijck, M., He, L., Mäe, M. A., Andrae, J., Ando, K., Del Gaudio, F., Nahar, K., Lebouvier, T., Laviña, B., Gouveia, L., et al. (2018) · Nature · doi:10.1038/nature25739 · Cited by 1,892
Establishment and Dysfunction of the Blood-Brain Barrier
Zhao, Z., Nelson, A. R., Betsholtz, C., & Zlokovic, B. V. (2015) · Cell · doi:10.1016/j.cell.2015.10.067 · Cited by 1,670
Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
Biessels, G. J., & Despa, F. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0048-7 · Cited by 1,454
Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease
Kisler, K., Nelson, A. R., Montagne, A., & Zlokovic, B. V. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.48 · Cited by 1,243
Iturria-Medina, Y., Sotero, R. C., Toussaint, P. J., Mateos-Pérez, J. M., Evans, A. C., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11934 · Cited by 1,202
Glymphatic failure as a final common pathway to dementia
Nedergaard, M., & Goldman, S. A. (2020) · Science · doi:10.1126/science.abb8739 · Cited by 1,145
O'Brien, J. T., & Thomas, A. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00463-8 · Cited by 1,136
Pericytes of the neurovascular unit: key functions and signaling pathways
Sweeney, M. D., Ayyadurai, S., & Zlokovic, B. V. (2016) · Nature Neuroscience · doi:10.1038/nn.4288 · Cited by 1,125
The role of brain vasculature in neurodegenerative disorders
Sweeney, M. D., Kisler, K., Montagne, A., Toga, A. W., & Zlokovic, B. V. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0234-x · Cited by 998
What are White Matter Hyperintensities Made of?
Wardlaw, J. M., Hernández, M. C. V., & Maniega, S. M. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001140 · Cited by 948
Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
Claassen, J. A. H. R., Thijssen, D. H. J., Panerai, R. B., & Faraci, F. M. (2021) · Physiological Reviews · doi:10.1152/physrev.00022.2020 · Cited by 1,005
Post-Stroke Cognitive Impairment and Dementia
Rost, N. S., Brodtmann, A. G., Pase, M. P., van Veluw, S. J., Biffi, A., Duering, M., Hinman, J. D., & Dichgans, M. (2022) · Circulation Research · doi:10.1161/circresaha.122.319951 · Cited by 864
A human brain vascular atlas reveals diverse mediators of Alzheimer’s risk
Yang, A. C., Vest, R. T., Kern, F., Lee, D. P., Agam, M., Maat, C. A., Losada, P. M., Chen, M. B., Schaum, N., Khoury, N., et al. (2022) · Nature · doi:10.1038/s41586-021-04369-3 · Cited by 797
Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques
Condello, C., Yuan, P., Schain, A., & Grutzendler, J. (2015) · Nature Communications · doi:10.1038/ncomms7176 · Cited by 718
Iadecola, C., Yaffe, K., Biller, J., Bratzke, L. C., Faraci, F. M., Gorelick, P. B., Gulati, M., Kamel, H., Knopman, D. S., Launer, L. J., et al. (2016) · Hypertension · doi:10.1161/hyp.0000000000000053 · Cited by 746
Self-citationVascular dysfunction—The disregarded partner of Alzheimer's disease
Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., Harrington, M. G., Pa, J., Law, M., Wang, D. J. J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.07.222 · Cited by 711
Self-citationThe overlap between vascular disease and Alzheimer’s disease - lessons from pathology
Attems, J., & Jellinger, K. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0206-2 · Cited by 739
“The pathophysiology of VaD has been critically reviewed recently [48,144-146].”
BackgroundAlzheimer’s disease: A matter of blood–brain barrier dysfunction?
Montagne, A., Zhao, Z., & Zlokovic, B. V. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171406 · Cited by 672
Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes
Nortley, R., Korte, N., Izquierdo, P., Hirunpattarasilp, C., Mishra, A., Jaunmuktane, Z., Kyrargyri, V., Pfeiffer, T., Khennouf, L., Madry, C., et al. (2019) · Science · doi:10.1126/science.aav9518 · Cited by 682
Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease
van de Haar, H. J., Burgmans, S., Jansen, J. F. A., van Osch, M. J. P., van Buchem, M. A., Muller, M., Hofman, P. A. M., Verhey, F. R. J., & Backes, W. H. (2016) · Radiology · doi:10.1148/radiol.2016152244 · Cited by 601
Claudin-5: gatekeeper of neurological function
Greene, C., Hanley, N., & Campbell, M. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0123-z · Cited by 583
The role of brain barriers in fluid movement in the CNS: is there a ‘glymphatic’ system?
Abbott, N. J., Pizzo, M. E., Preston, J. E., Janigro, D., & Thorne, R. G. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1812-4 · Cited by 593
Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease
Nelson, A. R., Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.016 · Cited by 559
Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics
Petersen, M. A., Ryu, J. K., & Akassoglou, K. (2018) · Nature reviews. Neuroscience · doi:10.1038/nrn.2018.13 · Cited by 527
El Husseini, N., Katzan, I. L., Rost, N. S., Blake, M. L., Byun, E., Pendlebury, S. T., Aparicio, H. J., Marquine, M. J., Gottesman, R. F., Smith, E. E., et al. (2023) · Stroke · doi:10.1161/str.0000000000000430 · Cited by 539
Toth, P., Tarantini, S., Csiszar, A., & Ungvari, Z. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00581.2016 · Cited by 522
Homocysteine, B Vitamins, and Cognitive Impairment
Smith, A. D., & Refsum, H. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050947 · Cited by 526
Neurovascular and Cognitive Dysfunction in Hypertension
Iadecola, C., & Gottesman, R. F. (2019) · Circulation Research · doi:10.1161/circresaha.118.313260 · Cited by 530
Self-citationPericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain
Kisler, K., Nelson, A. R., Rege, S. V., Ramanathan, A., Wang, Y., Ahuja, A., Lazic, D., Tsai, P. S., Zhao, Z., Zhou, Y., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4489 · Cited by 497
The Meningeal Lymphatic System: A New Player in Neurophysiology
Da Mesquita, S., Fu, Z., & Kipnis, J. (2018) · Neuron · doi:10.1016/j.neuron.2018.09.022 · Cited by 479
The neuropathology and cerebrovascular mechanisms of dementia
Raz, L., Knoefel, J. E., & Bhaskar, K. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.164 · Cited by 512
Merlini, M., Rafalski, V. A., Rios Coronado, P. E., Gill, T. M., Ellisman, M., Muthukumar, G., Subramanian, K. S., Ryu, J. K., Syme, C. A., Davalos, D., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.014 · Cited by 431
Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke
Hu, X., Silva, T. M. D., Chen, J., & Faraci, F. M. (2017) · Circulation Research · doi:10.1161/circresaha.116.308427 · Cited by 456
Astrocyte Regulation of Blood Flow in the BrainPreprint
MacVicar, B. A., & Newman, E. A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020388 · Cited by 443
Tarantini, S., Tran, C. H. T., Gordon, G. R., Ungvari, Z., & Csiszar, A. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2016.11.004 · Cited by 411
Mapping the Fine-Scale Organization and Plasticity of the Brain Vasculature
Kirst, C., Skriabine, S., Prado, A. V., Topilko, T., Bertin, P., Gerschenfeld, G., Verny, F., Topilko, P., Michalski, N., Tessier‐Lavigne, M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.028 · Cited by 370
Smith, E. E., Saposnik, G., Biessels, G. J., Doubal, F. N., Fornage, M., Gorelick, P. B., Greenberg, S. M., Higashida, R. T., Kasner, S. E., & Seshadri, S. (2017) · Stroke · doi:10.1161/str.0000000000000116 · Cited by 404
Alzheimer’s Disease and Vascular Aging
Cortes-Canteli, M., & Iadecola, C. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.10.062 · Cited by 400
“Multiple factors may contribute to vascular rarefaction in AD, including Aβ toxicity to vascular cells (20) and vascular risk factors such as hypertension (21).”
BackgroundSelf-citationTraumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link
Ramos‐Cejudo, J., Wısnıewskı, T., Marmar, C. R., Zetterberg, H., Blennow, K., de Leon, M. J., & Fossati, S. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.01.021 · Cited by 406
Beyond the neuron–cellular interactions early in Alzheimer disease pathogenesis
Henstridge, C. M., Hyman, B. T., & Spires-Jones, T. L. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0113-1 · Cited by 348
A Critical Role for the Vascular Endothelium in Functional Neurovascular Coupling in the Brain
Chen, B. R., Kozberg, M. G., Bouchard, M. B., Shaik, M. A., & Hillman, E. M. C. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.000787 · Cited by 370
Han, L., & Jiang, C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.023 · Cited by 358
Understanding the role of the perivascular space in cerebral small vessel disease
Brown, R., Benveniste, H., Black, S. E., Charpak, S., Dichgans, M., Joutel, A., Nedergaard, M., Smith, K. J., Zloković, B. V., & Wardlaw, J. M. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy113 · Cited by 346
Zhan, X., Stamova, B. S., & Sharp, F. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00042 · Cited by 361
Faraco, G., Sugiyama, Y., Lane, D., Garcia-Bonilla, L., Chang, H., Santisteban, M. M., Racchumi, G., Murphy, M., Van Rooijen, N., Anrather, J., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86950 · Cited by 350
Self-citationB-Lymphocyte-Mediated Delayed Cognitive Impairment following Stroke
Doyle, K. P., Quach, L. N., Solé, M., Axtell, R. C., Nguyen, T. V., Soler-Llavina, G. J., Jurado, S., Han, J., Steinman, L., Longo, F. M., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4098-14.2015 · Cited by 338
Montagne, A., Nikolakopoulou, A. M., Zhao, Z., Sagare, A. P., Si, G., Lazic, D., Barnes, S. R., Daianu, M., Ramanathan, A., Go, A., et al. (2018) · Nature Medicine · doi:10.1038/nm.4482 · Cited by 344
RetractedDietary salt promotes neurovascular and cognitive dysfunction through a gut-initiated TH17 response
Faraco, G., Brea, D., Garcia-Bonilla, L., Wang, G., Racchumi, G., Chang, H., Buendia, I., Santisteban, M. M., Segarra, S. G., Koizumi, K., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-017-0059-z · Cited by 343
Self-citationCan physical exercise in old age improve memory and hippocampal function?
Duzel, E., van Praag, H., & Sendtner, M. (2016) · Brain · doi:10.1093/brain/awv407 · Cited by 329
Preventing dementia by preventing stroke: The Berlin Manifesto
Hachinski, V., Einhäupl, K. M., Ganten, D., Alladi, S., Brayne, C., Stephan, B. C. M., Sweeney, M. D., Zloković, B. V., Iturria‐Medina, Y., Iadecola, C., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.06.001 · Cited by 324
Self-citationInoue, Y., Shue, F., Bu, G., & Kanekiyo, T. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00640-5 · Cited by 380
“Epidemiological studies have demonstrated that VCID is the second most common form of dementia after Alzheimer’s disease (AD), accounting for approximately 20% of dementia cases [2].”
BackgroundAnimal Models of Hypertension: A Scientific Statement From the American Heart Association
Lerman, L. O., Kurtz, T. W., Touyz, R. M., Ellison, D. H., Chade, A., Crowley, S. D., Mattson, D. L., Mullins, J. J., Osborn, J. L., Eirin, A., et al. (2019) · Hypertension · doi:10.1161/hyp.0000000000000090 · Cited by 351
Self-citationCardiovascular risk factors and future risk of Alzheimer’s disease
de Bruijn, R. F. A. G., & Ikram, M. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0130-5 · Cited by 350
Cerebrospinal fluid dynamics and intracranial pressure elevation in neurological diseases
Bothwell, S. W., Janigro, D., & Patabendige, A. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0129-6 · Cited by 348
Vascular Cognitive Impairment (VCI)
Rundek, T., Tolea, M. I., Ariko, T., Fagerli, E. A., & Camargo, C. J. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01170-y · Cited by 347
“these etiologies is chronic age-related dysregulation of CBF, but hypoxia, increased permeability of blood–brain barrier (BBB), endothelial dysfunction, systemic inflammation, and inflammatory clock of aging (iAge), which are tracked with multimorbidity, immunosenescence, frailty, and cardiovascular aging, are additio…”
BackgroundBlanchard, J. W., Bula, M., Davila-Velderrain, J., Akay, L. A., Zhu, L., Frank, A., Victor, M. B., Bonner, J. M., Mathys, H., Lin, Y.-T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0886-4 · Cited by 283
Blood‐brain barrier breakdown, neuroinflammation, and cognitive decline in older adults
Bowman, G. L., Dayon, L., Kirkland, R. E., Wojcik, J., Peyratout, G., Severin, I. C., Henry, H., Oikonomidi, A., Migliavacca, E., Bacher, M., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.06.2857 · Cited by 307
Rajeev, V., Fann, D. Y., Dinh, Q. N., Kim, H. A., Silva, T. M. D., Lai, M. K. P., Chen, C., Drummond, G. R., Sobey, C. G., & Arumugam, T. V. (2022) · Theranostics · doi:10.7150/thno.68304 · Cited by 320
“The degree of association between the risk factors and the vascular disease is thought to be dependent on age, lifestyle, genetic susceptibility, comorbidity of other diseases and even differential brain reserves as reviewed in detail previously [2,14,15].”
BackgroundBlood-Brain Barrier Overview: Structural and Functional Correlation
Alahmari, A. (2021) · Neural Plasticity · doi:10.1155/2021/6564585 · Cited by 299
“The brain requires 20% of the body’s glucose and oxygen, while accounting for just 2% of total body mass, and can quickly increase blood supply and oxygen transfer to its active areas, a mechanism that is known as neurovascular coupling [1, 2].”
BackgroundThe Pericyte: A Forgotten Cell Type with Important Implications for A lzheimer's Disease?
Winkler, E. A., Sagare, A. P., & Zloković, B. V. (2014) · Brain Pathology · doi:10.1111/bpa.12152 · Cited by 284
The interneuron energy hypothesis: Implications for brain disease
Kann, O. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.005 · Cited by 270
Wang, Q., Davis, P. B., Gurney, M. E., & Xu, R. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12296 · Cited by 257
Wardlaw, J. M., Makin, S., Hernández, M. C. V., Armitage, P. A., Heye, A. K., Chappell, F. M., Maniega, S. M., Sakka, E., Shuler, K., Dennis, M. S., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.09.006 · Cited by 268
Hussain, B., Fang, C., & Chang, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.688090 · Cited by 255
“These pathological markers are associated with BBB impairment, which causes microglial activation, neuroinflammation, degeneration of neurons, and cognitive impairment (Bhaskar et al., 2010; Iadecola, 2013).”
BackgroundBrain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer Aβ Peptides
Park, L., Uekawa, K., Garcia-Bonilla, L., Koizumi, K., Murphy, M., Pistik, R., Younkin, L., Younkin, S., Zhou, P., Carlson, G., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.311054 · Cited by 259
Self-citationClinical presentations and epidemiology of vascular dementia
Smith, E. E. (2017) · Clinical Science · doi:10.1042/cs20160607 · Cited by 260
Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A review
Poggesi, A., Pasi, M., Pescini, F., Pantoni, L., & Inzitari, D. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.116 · Cited by 257
Modifiable Risk Factors for Alzheimer’s Disease
Edwards III, G. A., Gamez, N., Escobedo Jr., G., Calderon, O., & Moreno-Gonzalez, I. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00146 · Cited by 253
The Role of Autophagy in Vascular Biology
Nussenzweig, S. C., Verma, S., & Finkel, T. (2015) · Circulation Research · doi:10.1161/circresaha.116.303805 · Cited by 245
Xiao, W., Su, J., Gao, X., Yang, H., Weng, R., Ni, W., & Gu, Y. (2022) · Microbiome · doi:10.1186/s40168-022-01255-6 · Cited by 252
Inflammatory markers and the risk of dementia and Alzheimer's disease: a meta-analysis
Darweesh, S. K. L., Wolters, F. J., Ikram, M. A., de Wolf, F., Bos, D., & Hofman, A. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.014 · Cited by 244
VEGF-A in Cardiomyocytes and Heart Diseases
Braile, M., Marcella, S., Cristinziano, L., Galdiero, M. R., Modestino, L., Ferrara, A. L., Varricchi, G., Marone, G., & Loffredo, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155294 · Cited by 245
Brain Endothelial Cells Are Exquisite Sensors of Age-Related Circulatory Cues
Chen, M. B., Yang, A. C., Yousef, H., Lee, D., Chen, W., Schaum, N., Lehallier, B., Quake, S. R., & Wyss-Coray, T. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.012 · Cited by 233
“Dysfunction and breakdown of this unit have been implicated in age-related neurodegeneration and manifest in reduced cerebral blood flow, leakage of toxic factors, and a general inability to maintain an optimal environment for neuronal and stem cell function (Bell et al., 2012; Iadecola, 2013; Sweeney et al., 2018; Zh…”
Ishii, M., & Iadecola, C. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.08.016 · Cited by 245
Self-citationCorriveau, R. A., Bosetti, F., Emr, M., Gladman, J. T., Koenig, J. I., Moy, C. S., Pahigiannis, K., Waddy, S. P., & Koroshetz, W. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0334-7 · Cited by 240
Zloković, B. V., Gottesman, R. F., Bernstein, K. E., Seshadri, S. S., McKee, A. C., Snyder, H. M., Greenberg, S. M., Yaffe, K. S., Schaffer, C. B., Yuan, C., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12157 · Cited by 252
Microglia exacerbate white matter injury via complement C3/C3aR pathway after hypoperfusion
Zhang, L.-Y., Pan, J., Mamtilahun, M., Zhu, Y., Wang, L., Venkatesh, A., Shi, R., Tu, X.-Q., Jin, K., Wang, Y., et al. (2019) · Theranostics · doi:10.7150/thno.35841 · Cited by 223
“Chronic cerebral hypoperfusion is closely related to cognitive impairment and vascular dementia [1, 2].”
BackgroundDietary salt promotes cognitive impairment through tau phosphorylation
Faraco, G., Hochrainer, K., Segarra, S. G., Schaeffer, S., Santisteban, M. M., Menon, A., Jiang, H., Holtzman, D. M., Anrather, J., & Iadecola, C. (2019) · Nature · doi:10.1038/s41586-019-1688-z · Cited by 236
Self-citationRemote ischaemic conditioning—a new paradigm of self-protection in the brain
Hess, D. C., Blauenfeldt, R. A., Andersen, G., Hougaard, K. D., Hoda, M. N., Ding, Y., & Ji, X. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.223 · Cited by 234
Emerging Concepts in Vascular Dementia: A Review
Bir, S. C., Khan, M. W., Javalkar, V., Toledo, E. G., & Kelley, R. E. (2021) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2021.105864 · Cited by 247
Consensus statement for diagnosis of subcortical small vessel disease
Rosenberg, G. A., Wallin, A., Wardlaw, J. M., Markus, H. S., Montaner, J., WOLFSON, L. I., Iadecola, C., Zloković, B. V., Joutel, A., Dichgans, M., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.172 · Cited by 228
Self-citationNeurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging
van de Haar, H. J., Jansen, J. F. A., van Osch, M. J. P., van Buchem, M. A., Muller, M., Wong, S. M., Hofman, P. A. M., Burgmans, S., Verhey, F. R. J., & Backes, W. H. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.06.006 · Cited by 207
Takeda, S., Sato, N., & Morishita, R. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00171 · Cited by 236
Rajeev, V., Chai, Y. L., Poh, L., Selvaraji, S., Fann, D. Y., Jo, D., Silva, T. M. D., Drummond, G. R., Sobey, C. G., Arumugam, T. V., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01590-1 · Cited by 241
Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management
Huang, Y.-Y., Chen, S.-D., Leng, X.-Y., Kuo, K., Wang, Z.-T., Cui, M., Tan, L., Wang, K., Dong, Q., & Yu, J.-T. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215644 · Cited by 252
Yan, N., Xu, Z., Qu, C., & Zhang, J. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107844 · Cited by 219
Cognitive Impairment in Multiple Sclerosis: Clinical, Radiologic and Pathologic Insights
DeLuca, G. C., Yates, R. L., Beale, H., & Morrow, S. A. (2014) · Brain Pathology · doi:10.1111/bpa.12220 · Cited by 228
The Relationship between Obstructive Sleep Apnea and Alzheimer’s Disease
Andrade, A. G., Bubu, O. M., Varga, A. W., & Osorio, R. S. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179936 · Cited by 216
Neuroprotective Effects of Angiotensin Receptor Blockers
Villapol, S., & Saavedra, J. M. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu197 · Cited by 219
Cognitive impairment and cardiovascular diseases in the elderly. A heart–brain continuum hypothesis
Abete, P., Della‐Morte, D., Gargiulo, G., Basile, C., Langellotto, A., Galizia, G., Testa, G., Canonico, V., Bonaduce, D., & Cacciatore, F. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.07.003 · Cited by 216
Single-Cell Analysis of Blood-Brain Barrier Response to Pericyte Loss
Mäe, M. A., He, L., Nordling, S., Vázquez-Liébanas, E., Nahar, K., Jung, B., Li, X., Tan, B. C., Foo, J. C., Cazenave‐Gassiot, A., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.317473 · Cited by 220
The impact of cerebrovascular aging on vascular cognitive impairment and dementia
Yang, T., Sun, Y., Lu, Z., Leak, R. K., & Zhang, F. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.007 · Cited by 214
Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation
Mendiola, A. S., Ryu, J. K., Bardehle, S., Meyer-Franke, A., Ang, K. K.-H., Wilson, C., Baeten, K. M., Hanspers, K., Merlini, M., Thomas, S., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0654-0 · Cited by 199
Aβ Amyloid Pathology Affects the Hearts of Patients With Alzheimer’s Disease
Troncone, L., Luciani, M., Coggins, M., Wilker, E. H., Ho, C.-Y., Codispoti, K. E., Frosch, M. P., Kayed, R., & del Monte, F. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.08.073 · Cited by 204
Sipilä, P. N., Heikkilä, N., Lindbohm, J. V., Hakulinen, C., Vahtera, J., Elovainio, M., Suominen, S., Väänänen, A., Koskinen, A., Nyberg, S. T., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00144-4 · Cited by 197
Metadata
- Authors
- Iadecola, C.
- Affiliations
- Weill Cornell Medicine (US)
- Corresponding author
- Iadecola, Costantino
- ORCID
- Iadecola, Costantino
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 80
- Issue
- 4
- Pages
- 844-866
- ISSN
- 0896-6273 (ISSN-L)
- PMC
- PMC3842016
- OpenAlex
- W2037426713
- Cited by
- 1,857
- References
- 364
- Citations by year
- 2026: 162 · 2025: 197 · 2024: 160 · 2023: 145 · 2022: 184 · 2021: 164 · 2020: 176 · 2019: 150 · 2018: 135 · 2017: 119 · 2016: 112 · 2015: 100 · 2014: 51
- FWCI
- 8.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL-96571, P01HL096571)
- National Institute of Neurological Disorders and Stroke (NS-37853, R01NS073666, R01NS037853)
- Topics
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Keywords
- vascular dementia, vascular cognitive impairment, Alzheimer's disease, mixed dementia, cerebrovascular disease, cerebral vasculature, white matter, neurovascular interactions, glia, vascular risk factors, dementia prevention, dementia treatment
- MeSH terms
- Alzheimer Disease, Cerebrovascular Circulation, Cognition Disorders, Humans, Dementia, Vascular, Stroke, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review